Overview
Maximilian Diehn is a Radiation Oncologist in Stanford, California. Dr. Diehn is rated as an Experienced provider by MediFind in the treatment of Progressive Osseous Heteroplasia. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
His clinical research consists of co-authoring 196 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
300 Pasteur Dr, Stanford, CA 94305
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Clarence Young is a Radiation Oncologist in Redwood City, California. Dr. Young is rated as an Advanced provider by MediFind in the treatment of Progressive Osseous Heteroplasia. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Progressive Osseous Heteroplasia.
Stanford Health Care
Sandra Zaky is a Radiation Oncologist in Stanford, California. Dr. Zaky is rated as a Distinguished provider by MediFind in the treatment of Progressive Osseous Heteroplasia. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.
Sara Huang is a Radiation Oncologist in San Francisco, California. Dr. Huang is rated as an Advanced provider by MediFind in the treatment of Progressive Osseous Heteroplasia. Her top areas of expertise are Breast Cancer, Prostate Cancer, Familial Prostate Cancer, and Pleuropulmonary Blastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Diehn isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Diehn isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Diehn isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Diehn isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Diehn isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Diehn isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Diehn isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Adult Soft Tissue SarcomaDr. Diehn isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AstrocytomaDr. Diehn isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Bone TumorDr. Diehn isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Diehn isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Diehn isExperienced. Learn about Breast Cancer.